Characterization of CD8+ cytotoxic T-lymphocyte responses after genetic immunization with retrovirus vectors expressing different forms of the hepatitis B virus core and e antigens

Journal of Virology

Volumn 71, Issue 5, 1997, Pages 3365-3374

  Townsend, Kay ^a   Sällberg, Matti ^a,b,c   O'Dea, Joanne ^a   Banks, Theresa ^a   Driver, David ^a   Sauter, Sybille ^a   Chang, Stephen M ^a   Jolly, Douglas J ^a   Mento, Steven J ^a   Milich, David R ^b   Lee, William T L ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; HEPATITIS B; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SEROCONVERSION; TRANSLATION REGULATION; VIRUS CHARACTERIZATION; VIRUS NUCLEOCAPSID;

EID: 1842369628     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.5.3365-3374.1997     Document Type: Article

References (46)

1. Bertoletti, A., C. Ferrari, F. Fiaccadori, A. Penna, R. Margolskee, H. J. Schlicht, P. Fowler, G. Guilhot, and F. V. Chisari. 1991. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc. Natl. Acad. Sci. USA 88:10445-10449.
2. Bruss, V., and W. H. Gerlich. 1988. Formation of transmembranous hepatitis B e-antigen by cotranslational in vitro processing of the viral precore protein. Virology 163:268-275.
3. Chada, S., C. E. DeJesus, K. Townsend, W. T. L. Lee, L. Laube, D. J. Jolly, S. M. W. Chang, and J. F. Warner. 1993. Cross-reactive lysis of human targets infected with prototypic and clinical human immunodeficiency virus type 1 (HIV-1) strains by murine anti-HIV-1 IIIB env-specific cytotoxic T lymphocytes. J. Virol. 67:3409-3417.
4. Doe, B., K. S. Steimer, and C. M. Walker. 1994. Induction of HIV-1 envelope (gp120)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gp120 is enhanced by enzymatic removal of N-linked glycans. Eur. J. Immunol. 24:2369-2376.
5. Emerman, M., and H. M. Temin. 1984. High-frequency deletion in recovered retrovirus vectors containing exogenous DNA with promoters. J. Virol. 50: 42-49.
6. Emerman, M., and H. M. Temin. 1984. Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell 39:459-467.
7. Ferrari, C., A. Bertoletti, A. Penna, A. Cavalli, A. Valli, G. Missale, M. Pilli, P. Fowler, T. Giuberti, and F. V. Chisari. 1991. Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. J. Clin. Invest. 88:214-222.
8. Ferrari, C., A. Penna, A. Bertoletti, A. Valli, A. D. Antoni, T. Giuberti, A. Cavalli, M. A. Petit, and F. Fiaccadori. 1990. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J. Immunol. 145:3442-3449.
9. Ferrari, C., A. Penna, T. Giuberti, M. J. Tong, E. Ribera, F. Fiaccadori, and F. V. Chisari. 1987. Intrahepatic nucleocapsid antigen-specific T cells in chronic active hepatitis Br. J. Immunol. 139:2050-2058.
10. Irwin, M. J., L. S. Laube, V. Lee, M. Austin, S. Chada, C. G. Anderson, K. Townsend, D. J. Jolly, and J. F. Warner. 1994. Direct injection of a recombinant retroviral vector induces human immunodeficiency virus-specific immune responses in mice and nonhuman primates. J. Virol. 68:5036-5044.
11. Ishikawa, T., S. Kakumu, K. Yoshioka, M. Yamada, K. Tanaka, Y. Higashi, M. Takayanagi, A. Okumuru, A. Kojima, and T. Tamura. 1993. Relative immunogenicity of hepatitis B virus-encoded antigens as targets for cytotoxic T-cell response. Immunology 80:313-318.
12. + T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection. J. Virol. 69:3358-3368.
13. Klavinskis, L. S., J. L. Whitton, and M. B. A. Oldstone. 1989. Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection. J. Virol. 63:4311-4316.
14. b mice. J. Immunol. 156:3687-3695.
15. Laube, L. S., M. Burrascano, C. E. Dejesus, B. D. Howard, M. A. Johnson, W. T. Lee, A. E. Lynn, G. Peters, G. S. Ronlov, K. S. Townsend, R. L. Eason, D. J. Jolly, B. Merchant, and J. F. Warner. 1994. Cytotoxic T lymphocyte and antibody responses generated in rhesus monkeys immunized with retroviral vector-transduced fibroblasts expressing human immunodeficiency virus type-1 IIIB ENV/REV proteins. Hum. Gene Ther. 5:853-862.
16. Lin, Y.-L., and B. A. Askonas. 1981. Biological properties of an influenza A virus-specific killer T cell clone: inhibition of virus replication in vivo and induction of delayed type hypersensitivity reactions. J. Exp. Med. 154:225-234.
17. Marinos, G., F. Torre, S. Chokshi, M. Hussain, B. E. Clarke, D. J. Rowlands, A. L. W. F. Eddelston, N. V. Naoumov, and R. Williams. 1995. Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus. Hepatology 22:1040-1049.
18. Maruyama, T., A. McLachlan, S. Iino, K. Koike, K. Kurokawa, and D. R. Milich. 1993. The serology of chronic hepatitis B infection revisited. J. Clin. Invest. 91:2586-2595.
19. McMichael, A. J. 1992. Role of class I molecules of the major histocompatibility complex in cytotoxic T-cell function in health and disease. Springer Semin. Immunopathol. 14:1-16.
20. Milich, D. R., J. E. Jones, J. L. Hughes, J. Price, A. K. Raney, and A. McLachlan. 1990. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc. Natl. Acad. Sci. USA 87:6599-6603.
21. Missale, G., A. Redeker, J. Person, P. Fowler, S. Guilhot, H. J. Schlicht, C. Ferrari, and F. V. Chisari. 1993. HLA-A31 and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J. Exp. Med. 177:751-762.
22. Mondelli, M., G. M. Vergani, A. Alberti, D. Vergani, B. Portmann, A. L. W. F. Eddleston, and R. Williams. 1982. Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J. Immunol. 129:2773-2778.
23. Ono, Y., H. Onda, R. Sasada, K. Igarashi, Y. Sugino, and K. Nishioka. 1983. The complete nucleotide sequences of the cloned hepatitis B virus DNA: subtype adr and adw. Nucleic Acids Res. 11:1747-1757.
24. Ou, J., O. Laub, and W. Rutter. 1986. Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen. Proc. Natl. Acad. Sci. USA 83:1578-1582.
25. Patek, P. Q., J. L. Collins, and M. Cohn. 1982. Activity and dexamethasone sensitivity of natural cytotoxic cell subpopulations. Cell. Immunol. 72:113-12.
26. Penna, A., F. V. Chisari, A. Bertolletti, G. Missale, P. Fowler, T. Giuberti, F. Fiaccadori, and C. Ferrari. 1991. Cytotoxic T lymphocytes recognize an HLA A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J. Exp. Med. 174:1565-1570.
27. Pushko, P., M. Sällberg, G. Borisova, U. Ruden, V. Bichko, B. Wahren, P. Pumpens, and L. Magnius. 1994. Identification of hepatitis B virus core protein regions exposed or internalized at the surface of HBcAg particles by scanning with monoclonal antibodies. Virology 202:912-920.
28. Quinnan, G. V., Jr., N. Kirmani, A. H. Rook, J. F. Manischewitz, L. Jackson, G. Moreschi, G. W. Santos, R. Saral, and W. H. Burns. 1982. Cytotoxic T cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N. Engl. J. Med. 307:7-13.
29. Reddehase, M. J., W. Mutter, K. Munch, H.-J. Buhring, and U. H. Koszinowski. 1987. CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J. Virol. 61: 3102-3108.
30. Rehermann, B., P. Fowler, J. Sidney, J. Person, A. Redeker, M. Brown, B. Moss, A. Sette, and F. V. Chisari. 1995. The cytotoxic T lymphocyte response to multiple hepatitis B viral polymerase epitopes during and after acute viral hepatitis. J. Exp. Med. 181:1047-1058.
31. Riddell, S. R., M. Elliott, D. A. Lewinsohn, M. J. Gilbert, L. Wilson, A. A. Manley, S. D. Lupton, R. W. Overell, T. C. Reynolds, L. Corey, and P. D. Greenberg. 1996. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nature Med. 2:216-223.
32. Sällberg, M., K. Townsend, M. Chen, J. O'Dea, T. Banks, D. J. Jolly, S. M. Chang, W. T. Lee, and D. R. Milich. Submitted for publication.
33. + cytotoxic T lymphocyte responses in vivo. J. Immunol. 152:1110-1119.
34. Schirmbeck, R., W. Böhm, K. Ando, F. V. Chisari, and J. Reimann. 1995. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J. Virol. 69:5929-5934.
35. Schodel, F., D. Peterson, J. Zheng, J. E. Jones, J. L. Hughes, and D. R. Milich. 1993. Structure of hepatitis B virus core and e-antigen. A single precore amino acid prevents nucleocapsid assembly. J. Biol. Chem. 268: 1332-1337.
36. Schwartz, F., N. Maeda, O. Smithies, R. Hickey, W. Edelmann, A. Skoultchi, and R. Kucherlapati. 1991. A dominant positive and negative selectable gene for use in mammalian cells. Proc. Natl. Acad. Sci. USA 88:10416-10420.
37. Sedivy, J. M., and P. A. Sharp. 1989. Positive genetic selection for gene disruption in mammalian cells by homologous recombination. Proc. Natl. Acad. Sci. USA 86:227-231.
38. Sharp, R. M., C. L. Durocher, and J. L. Parmenter. 1990. Production of baboon (Papio hamadryas) monoclonal antibodies by herpesvirus papio immortalized baboon lymph node cells. J. Immunol. Methods 126:287-294.
39. Staerz, U. D., H. Karasuyuma, and A. M. Garner. 1987. Cytotoxic T lymphocytes against soluble protein. Nature 329:449-451.
40. Tiollais, P., C. Pourcel, and A. Dejean. 1985. The hepatitis B virus. Nature 317:489-495.
41. Tsai, S. L., P. L. Chen, M. Y. Lai, P. M. Yang, J. L. Sung, J. H. Huang, and L. H. Hwang. 1992. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. J. Clin. Invest. 89:87-96.
42. Valenzuela, P., M. Quiroga, J. Zalvidar, P. Gray, and W. J. Rutter. 1980. The nucleotide sequence of the hepatitis B viral genome and the identification of the major viral genes, p. 57-70. In B. N. Fields, R. Jaenisch, and C. F. Fox (ed.), Animal virus genetics. Academic Press, New York, N.Y.
43. Vento, S., J. E. Hegarty, A. Alberti, C. J. O'Brien, G. J. M. Alexander, A. L. W. F. Eddleston, and R. Williams. 1985. T lymphocyte sensitization to HBcAg and T-cell mediated unresponsiveness to HBsAg in hepatitis B virus-related chronic liver disease. Hepatology 5:192-197.
44. Vitiello, A., G. Ishioka, H. M. Grey, R. Rose, P. Farness, R. Lafond, L. Yuan, F. V. Chisari, J. Furze, R. Bartholomeuz, and R. W. Chesnut. 1995. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans. J. Clin. Invest. 95:341-349.
45. Warner, J. F., C.-G. Anderson, L. Laube, D. J. Jolly, K. Townsend, S. Chada, and D. St. Louis. 1991. Induction of HIV-specific CTL and antibody responses in mice using retroviral vector-transduced cells. AIDS Res. Hum. Retroviruses 7:645-655.
46. d mice. Scand. J. Immunol. 42:557-563.